Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
McKesson
Accenture
McKinsey
Baxter
Queensland Health
Cipla
Cerilliant

Generated: November 13, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: erlotinib hydrochloride

« Back to Dashboard

erlotinib hydrochloride

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Osi Pharms TARCEVA erlotinib hydrochloride TABLET;ORAL 021743 NDA Genentech, Inc. 50242-062-01 30 TABLET in 1 BOTTLE (50242-062-01)
Osi Pharms TARCEVA erlotinib hydrochloride TABLET;ORAL 021743 NDA Genentech, Inc. 50242-063-01 30 TABLET in 1 BOTTLE (50242-063-01)
Osi Pharms TARCEVA erlotinib hydrochloride TABLET;ORAL 021743 NDA Genentech, Inc. 50242-064-01 30 TABLET in 1 BOTTLE (50242-064-01)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
QuintilesIMS
Boehringer Ingelheim
Cantor Fitzgerald
Fish and Richardson
Cerilliant
Julphar
Healthtrust